Skip to Content

Apyx Medical Corp APYX

Morningstar Rating
$1.55 +0.13 (9.15%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

APYX is trading at a 37% discount.
Price
$1.41
Fair Value
$3.84
Uncertainty
Extreme
1-Star Price
$7.73
5-Star Price
$2.25
Economic Moat
Hzfry
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if APYX is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.42
Day Range
$1.431.55
52-Week Range
$1.217.97
Bid/Ask
$1.37 / $1.55
Market Cap
$53.70 Mil
Volume/Avg
133,755 / 169,123

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.94
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
252

Comparables

Valuation

Metric
APYX
MMSI
ZIMV
Price/Earnings (Normalized)
23.9010.41
Price/Book Value
1.843.461.12
Price/Sales
0.943.340.98
Price/Cash Flow
19.5113.21
Price/Earnings
APYX
MMSI
ZIMV

Financial Strength

Metric
APYX
MMSI
ZIMV
Quick Ratio
4.533.810.84
Current Ratio
5.525.452.78
Interest Coverage
−7.968.07−1.51
Quick Ratio
APYX
MMSI
ZIMV

Profitability

Metric
APYX
MMSI
ZIMV
Return on Assets (Normalized)
−26.17%9.43%14.12%
Return on Equity (Normalized)
−47.60%14.77%31.63%
Return on Invested Capital (Normalized)
−29.80%11.47%18.79%
Return on Assets
APYX
MMSI
ZIMV
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesGmwjwnkpkBjtxsv$192.9 Bil
SYK
Stryker CorpXzxjmhlcGfzg$132.1 Bil
MDT
Medtronic PLCZggbhfdgyGxhtjq$109.3 Bil
BSX
Boston Scientific CorpVrmlbcdnVbvhkgk$100.9 Bil
EW
Edwards Lifesciences CorpQwnbtchcgYwxrqg$56.0 Bil
DXCM
DexCom IncDbftjgyktgBcd$54.1 Bil
ZBH
Zimmer Biomet Holdings IncVlstzhypGcf$26.6 Bil
ALGN
Align Technology IncXryhzjdHczqpn$24.7 Bil
PHG
Koninklijke Philips NV ADRSztstcqqzTbbvq$18.8 Bil
PODD
Insulet CorpSzlnlgqjDsjykxr$12.6 Bil

Sponsor Center